Source: Scientific Reports. Unidade: FMRP
Subjects: DOENÇA DE ALZHEIMER, ANTINEOPLÁSICOS, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BELLOZI, Paula Maria Quaglio et al. Neuroprotective effects of the anticancer drug NVP-BEZ235 (dactolisib) on amyloid-β 1-42 induced neurotoxicity and memory impairment. Scientific Reports, v. 6, 2016Tradução . . Disponível em: https://doi.org/10.1038/srep25226. Acesso em: 01 out. 2024.APA
Bellozi, P. M. Q., Lima, I. V. de A., Dória, J. G., Vieira, É. L. M., Campos, A. C., Candelario-Jalil, E., et al. (2016). Neuroprotective effects of the anticancer drug NVP-BEZ235 (dactolisib) on amyloid-β 1-42 induced neurotoxicity and memory impairment. Scientific Reports, 6. doi:10.1038/srep25226NLM
Bellozi PMQ, Lima IV de A, Dória JG, Vieira ÉLM, Campos AC, Candelario-Jalil E, Reis HJ, Teixeira AL, Ribeiro FM, Oliveira ACP de. Neuroprotective effects of the anticancer drug NVP-BEZ235 (dactolisib) on amyloid-β 1-42 induced neurotoxicity and memory impairment [Internet]. Scientific Reports. 2016 ; 6[citado 2024 out. 01 ] Available from: https://doi.org/10.1038/srep25226Vancouver
Bellozi PMQ, Lima IV de A, Dória JG, Vieira ÉLM, Campos AC, Candelario-Jalil E, Reis HJ, Teixeira AL, Ribeiro FM, Oliveira ACP de. Neuroprotective effects of the anticancer drug NVP-BEZ235 (dactolisib) on amyloid-β 1-42 induced neurotoxicity and memory impairment [Internet]. Scientific Reports. 2016 ; 6[citado 2024 out. 01 ] Available from: https://doi.org/10.1038/srep25226